DossierENTITY

MOTS-c

Coverage of MOTS-c in the Nexus archive.

Earliest in view: Jul 23 · 23:38 UTCMost recent: Jul 23 · 23:38 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 23 · 23:38 UTCTHE HILL
FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
The FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted to add peptides like BPC-157, KPV, TB-500, and MOTS-c to the list of substances compounding pharmacies can make, despite opposition from FDA scientists over concerns about their unproven benefits.